StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.98−0.04 (-3.43%)

Close on Oct 19, 2026Market cap $5.53MP/E –Yield –

Imunon free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Imunon's free cash flow for the twelve months ending Dec 31, 2025 was -$14.18M. For fiscal 2025 it was -$14.18M. The highest annual figure on record is -$7.18M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.18M–
FY2024Dec 31, 2024-$18.88M–
FY2023Dec 31, 2023-$19.47M–
FY2022Dec 31, 2022-$23.36M–
FY2021Dec 31, 2021-$16.54M–
FY2020Dec 31, 2020-$15.64M–
FY2019Dec 31, 2019-$20.61M–
FY2018Dec 31, 2018-$7.18M–
FY2017Dec 31, 2017-$16.68M–
FY2016Dec 31, 2016-$18.44M–
FY2015Dec 31, 2015-$20.94M–
FY2014Dec 31, 2014-$22.03M–
FY2013Dec 31, 2013-$9.58M–
FY2012Dec 31, 2012-$22.76M–
FY2011Dec 31, 2011-$23.32M–
FY2010Dec 31, 2010-$13.37M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$3.66M–
Q3 FY2025Sep 30, 2025-$4.44M–
Q2 FY2025Jun 30, 2025-$2.97M–
Q1 FY2025Mar 31, 2025-$3.11M–
Q4 FY2024Dec 31, 2024-$4.44M–
Q3 FY2024Sep 30, 2024-$4.06M–
Q2 FY2024Jun 30, 2024-$4.50M–
Q1 FY2024Mar 31, 2024-$5.89M–
Q4 FY2023Dec 31, 2023-$3.77M–
Q3 FY2023Sep 30, 2023-$4.71M–
Q4 FY2022Dec 31, 2022-$5.05M–
Q3 FY2022Sep 30, 2022-$4.70M–
Q2 FY2022Jun 30, 2022-$5.58M–
Q1 FY2022Mar 31, 2022-$8.03M–
Q4 FY2021Dec 31, 2021-$5.11M–
Q3 FY2021Sep 30, 2021-$3.85M–
Q2 FY2021Jun 30, 2021-$2.71M–
Q1 FY2021Mar 31, 2021-$4.86M–
Q4 FY2020Dec 31, 2020-$3.74M–
Q3 FY2020Sep 30, 2020-$3.97M–
Q2 FY2020Jun 30, 2020-$2.95M–
Q1 FY2020Mar 31, 2020-$4.98M–
Q4 FY2019Dec 31, 2019-$5.63M-193.4%
Q3 FY2019Sep 30, 2019-$4.55M–
Q2 FY2019Jun 30, 2019-$4.74M–
Q1 FY2019Mar 31, 2019-$5.68M–
Q4 FY2018Dec 31, 2018$6.03M–
Q3 FY2018Sep 30, 2018-$4.27M–
Q2 FY2018Jun 30, 2018-$4.25M–
Q1 FY2018Mar 31, 2018-$4.68M–
Q4 FY2017Dec 31, 2017-$4.23M–
Q3 FY2017Sep 30, 2017-$5.11M–
Q2 FY2017Jun 30, 2017-$4.20M–
Q1 FY2017Mar 31, 2017-$3.15M–
Q4 FY2016Dec 31, 2016-$4.68M–
Q3 FY2016Sep 30, 2016-$4.73M–
Q2 FY2016Jun 30, 2016-$4.27M–
Q1 FY2016Mar 31, 2016-$4.77M–

More Imunon figures

See a number that looks wrong?